TAMMY JERNIGAN: Open Payments
NPI 1497070585 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 10 payments from 8 companies in 2025. Trend: 2023 $1,022 · 2024 $1,834 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $205 |
| AstraZeneca Pharmaceuticals LP | 2 | $192 |
| Recor Medical Inc | 1 | $145 |
| Insulet Corporation | 1 | $114 |
| Phathom Pharmaceuticals, Inc. | 1 | $90 |
| Lilly USA, LLC | 1 | $84 |
| Medtronic, Inc. | 1 | $60 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Ozempic, Paradise Ultrasound Renal Denervation System, OMNIPOD, BREZTRI, VOQUEZNA, ZEPBOUND, FARXIGA, MINIMED 780G.
Industry payments across FL — which companies pay providers there.
